Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray. Academic Article uri icon

Overview

abstract

  • Corticotropin-releasing hormone (CRH) is anxiogenic when microinjected into the dorsal periaqueductal gray (DPAG). Microinjection of alpha-helical-CRH9-41 (0.5 microgram), a CRH receptor antagonist, however, failed to change anxiety levels. The objective of this study was to verify if this compound has any effect in the anxiogenic behavior of rats submitted to 4 hr of restraint stress 24 hr before the test in an elevated plus maze. Results showed that stressed rats had a decreased exploration of open arms without changing the number of enclosed arm entries. The stress effect was reversed by intra-DPAG injection of alpha-helical-CRH9-41 (0.5 microgram). These results suggest that the anxiogenic behavior of rats previously stressed by forced immobilization might involve facilitation of CRH-mediated neurotransmission in the DPAG.

publication date

  • January 1, 2000

Research

keywords

  • Anxiety Disorders
  • Cerebral Ventricles
  • Corticotropin-Releasing Hormone
  • Peptide Fragments
  • Periaqueductal Gray
  • Receptors, Corticotropin-Releasing Hormone

Identity

Scopus Document Identifier

  • 0033752761

PubMed ID

  • 11091933

Additional Document Info

volume

  • 12

issue

  • 2